Exploring how maternal nutrition affects neonatal growth
Exploring the Fuel-mediated Programming of Neonatal Growth
This study looks at how what pregnant women eat affects their babies' growth and health, especially in different ethnic groups.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2821 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT02273297 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a diverse cohort of pregnant women and their infants to investigate the relationship between fetal over-nutrition and the development of obesity, metabolic, and cardiovascular issues in offspring. The study will follow participants longitudinally, collecting data on maternal factors and their impact on neonatal growth. By focusing on a range of ethnic backgrounds, the research seeks to provide insights into how different populations may be affected by maternal nutrition during pregnancy.
Who should consider this trial
Good fit: Ideal candidates include pregnant women under 23 weeks of gestation living in Colorado.
Not a fit: Patients with multiple gestations or preexisting conditions such as cancer, psychiatric diseases, or diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved guidelines for maternal nutrition, potentially reducing obesity and related health issues in future generations.
How similar studies have performed: Other studies have shown success in linking maternal nutrition to offspring health, suggesting that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women and infants * Prior to 23 completed weeks of gestation * Live in Colorado Exclusion Criteria: * Multiple gestation * Preexisting * cancer * psychiatric disease * steroid-dependent asthma, or * diabetes * Previous premature delivery prior to 25 weeks gestation or fetal demise
Where this trial is running
Aurora, Colorado
- University of Colorado Denver — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Dana Dabelea, MD, PhD — University of Colorado, Denver
- Study coordinator: Dana Dabelea, MD, PhD
- Email: Dana.Dabelea@ucdenver.edu
- Phone: 303-724-4414
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.